Dose Finding Phase 1 Study of the Treatment of Metastatic Melanoma With MPC-6827 in Combination With Temozolomide.
Phase of Trial: Phase I
Latest Information Update: 19 Aug 2010
At a glance
- Drugs Temozolomide; Verubulin
- Indications Cancer metastases; Malignant melanoma
- Focus Adverse reactions
- 19 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2010 Final data will be reported at ASCO 2010, according to a Myriad Pharmaceuticals media release.
- 18 Nov 2009 Initial results have been announced by Myriad in a media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History